3rd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for GILEAD SCIENCES INC

Period 3rd Quarter 2022 Filed Oct 20, 2022 Signed by Brian Pomper

Official filing
Firm
AKIN GUMP STRAUSS HAUER & FELD
Client
GILEAD SCIENCES INC
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; general healthcare issues.

LobbyistCovered position, as disclosed
LOUIS AGNELLO —
VIRGIL MILLER New Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3506 (117th)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; Issues related to intellectual property rights for COVID therapeutics

LobbyistCovered position, as disclosed
STEPHEN KHO New —
BRIAN ARTHUR POMPER —

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 3506 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.